Role of oral teriflunomide in the management of multiple sclerosis

Código QR

Role of oral teriflunomide in the management of multiple sclerosis

Radu Tanasescu,1,2 Nikos Evangelou,1 Cris S Constantinescu1 1Academic Division of Clinical Neurology, University of Nottingham, Nottingham, UK; 2Department of Neurology, Colentina Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania Abstract: The landscape of the treatment...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tanasescu R, Evangelou N, Constantinescu CS
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/80d40c8d91304dd493f0e94de2b27fd1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Clemens Warnke, et al.
Publicado: (2009)

Cannabinoids in the management of spasticity associated with multiple sclerosis
por: Anna Maria Malfitano, et al.
Publicado: (2008)

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
por: Warnke C, et al.
Publicado: (2011)

The role of glatiramer acetate in the early treatment of multiple sclerosis
por: David W Brandes
Publicado: (2010)

Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
por: Julie A Murphy, et al.
Publicado: (2010)

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
por: Dubey D, et al.
Publicado: (2015)

Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
por: Babij R, et al.
Publicado: (2015)

Cognitive dysfunction in pediatric multiple sclerosis
por: Suppiej A, et al.
Publicado: (2014)

The Multiple Sclerosis Treatment Optimization Program
por: Annette Langer‐Gould, et al.
Publicado: (2021)

Neurobehavioral burden of multiple sclerosis with nanotheranostics
por: Sriramoju B, et al.
Publicado: (2015)

Association between smoking and cognitive impairment in multiple sclerosis
por: Özcan ME, et al.
Publicado: (2014)

Gut microbiome is associated with multiple sclerosis activity in children
por: Mary K. Horton, et al.
Publicado: (2021)

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
por: Lugaresi A, et al.
Publicado: (2013)

Measuring treatment response to advance precision medicine for multiple sclerosis
por: Peter A. Calabresi, et al.
Publicado: (2021)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
por: Castrop F, et al.
Publicado: (2013)

Disease-modifying therapies in relapsing&ndash;remitting multiple sclerosis
por: Fabricio Gonz&aacute;lez-Andrade, et al.
Publicado: (2010)

Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
por: Hayes KC
Publicado: (2011)

Attention deficits in Japanese multiple sclerosis patients with minor brain lesion loads
por: Takeda A, et al.
Publicado: (2011)

Walking impairment in patients with multiple sclerosis: exercise training as a treatment option
por: Robert W Motl, et al.
Publicado: (2010)

The role of microglia in multiple sclerosis
por: Luo C, et al.
Publicado: (2017)

Cluster headache as a first manifestation of multiple sclerosis: case report and literature review
por: Mijajlović MD, et al.
Publicado: (2014)

When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
por: Kachuck NJ
Publicado: (2011)

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity
por: Veauthier C, et al.
Publicado: (2015)

Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options
por: Wang S, et al.
Publicado: (2014)

Review of the clinical evidence for interferon &beta; 1a (Rebif&reg;) in the treatment of multiple sclerosis
por: Francesco Manfredonia, et al.
Publicado: (2008)

Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature
por: Hsieh PC, et al.
Publicado: (2013)

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing&ndash;remitting multiple sclerosis?
por: Mezei Z, et al.
Publicado: (2012)

Disconnection of the hippocampus and amygdala associated with lesion load in relapsing–remitting multiple sclerosis: a structural and functional connectivity study
por: Zhou F, et al.
Publicado: (2015)

Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report
por: De Pasquale C, et al.
Publicado: (2014)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
por: Radu Constantinescu
Publicado: (2008)

Emerging role of sertindole in the management of schizophrenia
por: Stephanie L Cincotta, et al.
Publicado: (2010)

Current and emerging treatments for amyotrophic lateral sclerosis
por: Stefano Zoccolella, et al.
Publicado: (2009)

Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Jay D Kranzler, et al.
Publicado: (2010)

Role of extended release quetiapine in the management of bipolar disorders
por: Rayan K Al Jurdi, et al.
Publicado: (2010)

New treatment options in the management of fibromyalgia: role of pregabalin
por: Grazyna Zareba
Publicado: (2008)

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
por: Introna A, et al.
Publicado: (2018)

The role of family therapy in the management of schizophrenia: challenges and solutions
por: Caqueo-Urízar A, et al.
Publicado: (2015)

New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
por: Warren CG, et al.
Publicado: (2013)

The hospital anxiety and depression scale, in patients with multiple sclerosis
por: Pais-Ribeiro JL, et al.
Publicado: (2018)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Bernhard T Baune
Publicado: (2008)